Regulation News: Breaking Regulation News, Comments and Articles. - Page: 3

03:01 EDT 4th July 2015 | BioPortfolio

Regulation News - Page: 3RSS

Read the latest Regulation News from around the world, updated every five minutes. Breaking stories from leading news and press agencies, bloggers and experts on Regulation.

Search or Follow Our Regulation - Page: 3 News…

If you are looking for more stories, you may wish to search our extensive news archives for relevant stories: Search for More Regulation - Page: 3 News.

Showing "regulation regulatory" News Articles 51 to 75 of 6,400+

Wednesday 1st July 2015

Indoor tanning not limited to tanning salons

(Reuters Health) - The availability of indoor tanning outside of tanning salons may promote risky use because of lax regulation, U.S. researchers say.

IPSEN: Disclosure of Transactions in Own Shares Between 24/06/2015 and 30/06/2015

Regulatory News: Date Number ofshares Weightedaverageprice (in €) Amount (in €) 24/06/2015 PURCHASE 4,000 49.43 197,716.00 25/06/2015 PURCHASE 4,000 50.41 201,656.00 26/06/2015 PURCHASE 4,000 50.5...

Pennsylvania Health Secretary Issues Statement on Attorney General's Lawsuit Against Nursing Home Chain

HARRISBURG, Pa., July 1, 2015 /PRNewswire-USNewswire/ -- Secretary of Health Karen Murphy said she was deeply concerned by the allegations of inadequate care in 12 nursing homes operated by Golden Senior Living identified in the lawsuit filed on Wednesday by Attorney General Kathleen Kane. "The Department of Health takes very seriously its duty to protect the health of the general public, especia...

Regulation of the NADH pool and NADH/NADPH ratio redistributes acetoin and 2,3‐butanediol proportion in Bacillus subtilis

Bacillus subtilis produces acetoin as a major product accompanied with several NADH‐dependent byproducts, especially 2,3‐butanediol. In this study, the down‐regulation of the NADH pool and redistribution of NADH/NADPH were proposed as a method ...

EU biocidal product registry upgrade announced

R4BP 3.3 now has updated functionalities to help both industry and authorities make better use of their time, multitask, and meet their regulatory obligations

Obama Scores 'Fast-Track' Trade Promotion Authority, Paving Way For TPP

With fast-track negotiating authority, President Obama seeks to finalize the Trans-Pacific Partnership, which contains a dedicated cosmetics annex with "specific regulatory coherence provisions" aimed at lowering international trade barriers and prom...

News and press releases: Regulatory information - Electronic application becomes mandatory today

EMA application forms should be used for all human and veterinary centralised procedure applications as of 1 July 2015

Cal/OSHA Issues High Heat Advisory for Sacramento Valley, Northern California as Temperatures Rise

OAKLAND, Calif., July 1, 2015 /PRNewswire-USNewswire/ -- Cal/OSHA is urging all employers, particularly those in the Sacramento Valley and adjacent foothills, to protect their outdoor workers from heat illness. The National Weather Service has issued an excessive heat warning for these areas, where temperatures are expected to rise to highs of 115 degrees through Friday morning. Heat warnings are ...

Leading R&D Organizations Deploy Instem SEND Solutions

Organizations Around the Globe Continue to Become SEND-Enabled with Instem’s Submit Software Platform Following 2014 FDA Mandate Instem, a leading provider of IT solutions to the global early development healthcare market, is pleased to announce that its customers are deploying Instem SEND solutions at a record pace. Numerous world- leading healthcar...

CEL-SCI Reports June Patient Enrollment in Its Phase 3 Head and Neck Cancer Trial

CEL-SCI Corporation (NYSE MKT: CVM) ("CEL SCI" or the "Company") today announced that in June it has enrolled 25 patients in its ongoing Phase 3 trial of its investigational immunotherapy Multikine* (Leukocyte Interleukin, Injection) in just diagnosed, not yet treated patients with head and neck cancer. Total patient enrollment is now 48

GlySure Secures CE Mark and Launches World’s First Continuous Intravascular Glucose Monitoring System

System addresses unmet need for continuous glucose monitoring in the ICU, a potential market in excess of $5 billion GlySure Limited today announced that it has secured the CE Mark for the world’s first and only Continuous Intravascular Glucose Monitoring System (CIGMS). The initial use of the GlySure™ CIGMS is to enhance blood glucose management a...

PPD Creates Pediatric Investigator Network to Enhance Global Trials Capabilities

Offers clients enhanced startup, enrollment and data quality for pediatric clinical trials Pharmaceutical Product Development, LLC (PPD) has formalized relationships with eight investigator sites as part of a pediatric investigator network (PIN) the company has established to further enhance its

Exelixis Provides Update on Genentech’s Pending New Drug Application for Cobimetinib, an Exelixis-Discovered Compound

Yesterday, Exelixis’ (NASDAQ:EXEL) partner Genentech, a member of the Roche Group, informed Exelixis that, in order to accommodate its review of a supplemental data submission, the U.S. Food and Drug Administration (FDA) has extended the Prescription Drug User Fee Act (PDUFA) action date for its review of Genentech’s New Drug Application (NDA) for cobi...

Sarepta Therapeutics Appoints Henri Termeer as Advisor to the Company

Sarepta Therapeutics, Inc. (NASDAQ:SRPT), a developer of innovative RNA-targeted therapeutics, today announced Henri Termeer, industry leader and former CEO of Genzyme, will be a key advisor to the Company. “I am honored to have Henri Termeer, a pioneer of rare disease companies, serve as an advisor as we seek FDA approval for our lead product ...

St. Joseph’s Health Now a Member of Trinity Health

Livonia, Mich. (PRWEB) July 01, 2015 With all final regulatory approvals in place and the transition of Catholic sponsorship complete, St. Joseph’s Health, located in Syracuse, ...

Teva and Xenon Provide Update on TV-45070 Phase 2b Study in Osteoarthritis Pain

TV-45070 4% and 8% did not demonstrate statistically significant difference from placebo in efficacy endpoints in Phase 2b study in pain due to osteoarthritis of the knee. TV-45070 demonstrated a favorable safety and tolerability profile, with no drug-related serious adverse events. Low drug plasma levels couple...

BRIEF-Guangzhou Improve Medical Instruments gets regulatory approval for assets acquisition

July 1 (Reuters) - Guangzhou Improve Medical Instruments Co Ltd

BRIEF-Chongqing Lummy Pharma gets regulatory approval for share private placement

* Says gets securities regulator's approval for share private placement

Echo Therapeutics Announces New Website Launch

ISELIN, N.J., July 1, 2015 /PRNewswire/ -- Echo Therapeutics, Inc. (NASDAQ: ECTE), a medical device company focused on non-invasive continuous glucose monitoring and associated technologies, today announced the launch of its new and completely re-designed corporate website Echo's new site provides quick and intuitive access to Echo's technology and enhances the quality and availab...

BRIEF-Beijing Beilu Pharmaceutical gets regulatory approval for private placement

* Says gets securities regulator's approval for private placement of shares

Massachusetts State Regulations & Policies Survey

Earlier this year, Governor Baker issued an Executive Order requiring all executive branch agencies to review current state regulations and policies to determine whether they need to be revised, revamped or removed. The goal is to streamline government functions by eliminating duplicative, unnecessary or inconsistent requirements. (The Executive Order can be found here:

Don't Market Yourself Into A Corner With Natural Claims – UL Exec

Natural personal care is a compelling opportunity, but "don't expose yourself for marketing points," UL exec Matthew Cerundolo told HBA Global Expo attendees June 10 during a session on regulatory and safety compliance for natural products. With deba...

UK backs early access to BMS’s Opdivo for lung cancer

Patients with lung cancer in the UK can now get treatment with Bristol-Myers Squibb's Opdivo under a new scheme designed to accelerate access to new drugs.Opdivo (nivolumab) has been included in the UK's Early Access to Medicines Scheme (EAMS) for pa...

Synergy Pharmaceuticals Appoints Timothy Callahan and Richard Daly to Board of Directors

Synergy Pharmaceuticals Inc. (NASDAQ:SGYP) today announced that it has appointed Timothy Callahan and Richard Daly as new independent directors to its board. Both Mr. Callahan and Mr. Daly have direct experience in primary care and gastrointestinal markets and have led large organizational change and successful business growth, in a variety of areas, inclu...

MEI Pharma to Present at Cantor Fitzgerald Healthcare Conference

SAN DIEGO, July 1, 2015 /PRNewswire/ -- MEI Pharma, Inc. (Nasdaq: MEIP), an oncology company focused on the clinical development of novel therapies for cancer, announced today that Daniel P. Gold, Ph.D., President and Chief Executive Officer, will present at the inaugural Cantor Fitzgerald Healthcare Conference on Wednesday, July 8, 2015 at 8:30 a.m. Eastern time from Le Parker Meridien in Ne...


News Quicklinks